ARCT

Arcturus Therapeutics Holdings, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website arcturusrx.com
Employees(FY) 170
ISIN nan

Performance

-17.42%

-23.55%

-24.51%

-45.7%

-48.72%

YTD

-33.68%

Profile

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.

Advanced Technical Analysis

Technical Analysis of ARCT 2024-11-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors as the market appears to be st...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ARCT

Stock Rank

Recent News & Updates

2024-11-18 20:00
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference(Business Wire)
2024-11-18 07:00
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference(Businesswire)
2024-11-14 01:00
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.(Business Wire)
2024-11-13 12:00
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.(Businesswire)
2024-11-11 17:19
Arcturus Therapeutics Gets FDA Greenlight for H5N1 Pandemic Flu Vaccine Trial(MT Newswires)
2024-11-11 16:01
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial(Business Wire)
2024-11-11 03:01
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial(Businesswire)
2024-11-09 09:25
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-11-08 12:15
Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-07 16:01
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress(Business Wire)
2024-11-07 13:29
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ...(Yahoo Finance)
2024-11-07 04:55
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-11-07 03:48
Arcturus Therapeutics: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-07 03:01
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress(Businesswire)
2024-11-06 07:35
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Report Preview: What To Look For(GuruFocus.com)
2024-11-04 10:05
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect(Zacks)
2024-10-31 16:01
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024(Business Wire)
2024-10-31 04:01
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024(Businesswire)
2024-10-30 12:00
Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock?(Zacks)
2024-10-24 07:23
Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain(Simply Wall St.)
2024-10-23 04:00
A slow start for self-amplifying mRNA vaccines(Pharmaceutical Technology)
2024-10-01 10:46
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty(Zacks)
2024-09-30 11:12
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses(Benzinga)
2024-09-30 08:00
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination(Business Wire)
2024-09-29 20:00
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination(Prnewswire)
2024-09-16 11:28
Here's Why Investors Should Invest in Arcturus Stock Now(Zacks)
2024-09-13 08:48
Arcturus Therapeutics, CSL's Updated Covid-19 Vaccine Approved in Japan(MT Newswires)
2024-09-13 08:15
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma(PR Newswire)
2024-09-13 07:13
New Strong Buy Stocks for September 13th(Zacks)
2024-09-12 20:15
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma(Prnewswire)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.